Keywords

6.1 History of OA in Japan

Occupational asthma (OA) is one of the most common forms of occupational lung disease in many industrialized countries, and it accounts for 9–15 % of adult asthma [1].

The first case of OA in Japan was reported in 1926 as “Asthma attack induced by working with American red cedar wood.” When large amounts of American red cedar were imported for reconstruction after the Great Kanto Earthquake, carpenters suffered from asthma when processing this cedar. An epidemiological study revealed that approximately 10 % of carpenters were suffering from OA due to cedar. Therefore, import of the cedar was stopped and such OA was no longer seen.

After IgE was discovered in 1966, OA began to be studied from an immunological perspective. The first OA to be identified in Japan was konjac asthma. At that time, bronchial asthma apparently caused by “Maiko” powder was known among the residents living near konjac milling plants and the employees of these plants. A group from the First Department of Internal Medicine at Gunma University studied a detailed field survey in Shimonita that identified OA induced by inhaling Maiko powder, which they called konjac asthma and reported in 1951 [2]. After that, many OAs were reported as sea squirt asthma, silkworm phosphorus hair asthma, buckwheat asthma, silkworm cocoon asthma, and shiitake mushroom asthma in 1996, 1996, 1970, 1971, and 1985, respectively [3, 4].

6.2 Epidemiology of Occupational Asthma in Japan

The rate of the OAs is about 2–15 % of all asthmatics in Japan. However, we do not have correct data of incidence and prevalence of OA. Since it is possible that many patients are treated for asthma without diagnosis of OA, the actual prevalence is probably higher.

Among persons involved in specific types of work, the prevalence of OA depends on the allergens to which they are exposed or the work environment, and there are many reports about its prevalence (Table 6.1) [5, 6].

Table 6.1 Estimated preverence of work-related asthma from cross-sectional studies in Japan

It is a serious problem that a high prevalence was shown around some factories because allergens released from the workplace cause residents living around the plants to develop asthma. We found that many residents living around a konjac factory had konjac asthma, and we proposed that this should be called “environmental asthma” (Table 6.2) [7].

Table 6.2 The number of Konjac asthma patients depend on the distance from the factories

6.3 Allergens

The causative allergens are varied and sometimes unexpected. A part of substances that have been reported in Japan are summarized in Table 6.3 [7].

Table 6.3 Reported occupational allergens in Japan

Causative allergens are divided into allergens of high molecular weight, such as those derived from animals and plants, and allergens of low molecular weight, such as chemicals and metals. According to the development of industry, the incidence of asthma induced by high molecular weight compounds is decreasing. On the other hand, asthma induced by low molecular weight substances is increasing and has become a serious problem, recently [5, 6]. The problems in OAs caused by chemicals are that the specific IgE antibody cannot be easily detected and diagnosis is difficult.

6.4 Traditional Occupational Asthma in Japan

6.4.1 Konjac Asthma

As I have described previously, the first OA to be identified immunologically in Japan was konjac asthma [2]. Konjac root is dried and ground into powder in the process of manufacturing the food known as konjac (no calorie food). Maiko is a fine konjac root powder that is blown by air pressure to obtain konjac powder for commercial use. Much of the Maiko powder is dispersed in the air and induces asthma in the plant workers by inhalation. The prevalence of konjac asthma was 16.6 % among employees in konjac mills, and the age of onset was different but mostly under 30 years.

The purified allergen of konjac asthma named Ag40D-2 is an acidic protein of about 24,000 daltons. Its ratio of basic to acidic amino acids is 1:3.7 and it induces a strong P-K reaction.

The immediate skin reaction to a purified Maiko powder allergen is positive in 100 % of konjac asthma patients, but negative in non-konjac asthma patients.

When the asthma was discovered, konjac making was an important industry in the Shimonita area and 40 % of the population were involved in producing konjac flour. Therefore, specific immunotherapy was developed because of the difficulty in changing jobs. When its efficacy was assessed, it was remarkably effective in 6/35 persons (17.1 %) and was effective in 18 (51.4 %) [3, 4].

After the konjac asthma was reported, companies began to improve the work environment. As a result of great effort, no one has developed konjac asthma since the late 1980s.

6.4.2 Sea Squirt Asthma

Sea squirt asthma is triggered by the inhalation of fluid from protochordate sea squirts that is adherent to cultured oysters. Cultivation of oysters in the Hiroshima region has been done for 400 years, and many people are engaged in the task of oyster husking. There were no reports before World War II, but employees complained of the onset of asthma associated with their work from around 1960. This asthma was reported in 1963 by Mitsui. In addition, detailed studies revealed that this type of asthma was induced by the inhalation of sea squirt components adherent to oysters. Such OA was named sea squirt asthma in 1966 [8].

The cause of its onset was improved farming methods that allowed farming of oysters in deep water since around 1952, so that sea squirts became attached to the oysters. Because work was often done under rough conditions with poor ventilation, workers inhaled a lot of sea squirt components.

From the investigation done at the time, the prevalence was 29 % (443 out of 1,528 people) and it reached 45.8 % in some towns. Because the industry has mostly female employees, there is a majority of female patients. Half of the patients develop asthma within 5 years of starting work.

Separation and purification of sea squirt allergen was carried out and four allergens (H, Gi-rep, Ei-M, and DIIIa) were identified. Especially Gi-rep and Ei-M were effective for immunotherapy.

The skin reaction to sea squirt allergen is positive in 91.3 % of sea squirt asthma patients. When an allergen inhalation challenge test was done with sea squirt allergen, four out of nine sea squirt asthma patients were positive.

Initially immunotherapy was done with the crude allergen and the efficacy rate was high at about 75 %. However, immunotherapy with the crude allergen caused side effects such as induction of asthma or urticaria. In contrast, therapy with the purified allergen has a higher efficacy rate of 91.5 % and causes fewer side effects [8].

As a result of great effort to improve work environments, the number of patients has recently shown a significant decrease due to improvement of the work environment.

6.5 Emerging Occupational Asthma

6.5.1 High Molecular Weight Allergen

The pollen of vegetables and fruits or spores of mushrooms have become causative allergens along with the increase of greenhouse culture. Especially, shiitake mushroom, tomato, and strawberry were not recognized as causing asthma when open-field cultivation was common.

Furthermore, it was reported that a furniture craftsman developed asthma by inhalation of the dust of Albizia falcataria (Falcata wood), which is a broad-leafed tree and began to be imported recently.

6.5.2 Low Molecular Allergen

There have been reports about occupational allergy induced by ortho-phthalaldehyde, which is used as a disinfectant solution for fiberscopes. Cases of ortho-phthalaldehyde-induced anaphylaxis began to be reported from around 2006. For example, anaphylaxis has occurred immediately after observation by a laryngeal fiberscope. Since various new chemicals will be developed in the future, we always have to pay attention to allergies caused by chemicals.

6.6 The First Guidelines for Occupational Allergic Diseases in Japan

6.6.1 Necessity of Guideline

It is extremely important to identify occupational allergic disease cases in their early stages and take appropriate preventive measures for the social lives of patients. A guideline was released in Canada as long ago as 1998, while the American Thoracic Society (ATS) guidelines were published in 2005 [1]. In the same year, other guidelines were published in the United Kingdom. Other guidelines that described diagnosis and management in detail were published by The American College of Chest Physicians, while more guidelines were released in Spain (in 2006) and in Singapore (in 2008). These guidelines show wide recognition of the importance of occupational asthma.

In Japan, a large number of case reports have been accumulated on occupational allergic diseases. However, because of the occupational features of the diseases, only case reports have been presented in many cases. Although guidelines for individual allergic diseases have been published by allergologic associations, the descriptions of occupational factors are generally minimal. It is extremely important that the guideline for diagnosis and management of occupational allergic diseases have been published in 2013 for the first time in Japan [5] (Fig. 6.1).

Fig. 6.1
figure 1

First Japanese guideline for occupational allergic diseases 2014

This guideline is designed to assist healthcare professionals engaging in ordinary diagnosis and management of allergic diseases to practice early detection and treatment and early prevention in patients with allergic diseases induced and worsened by occupational factors. We hope that this guideline will be used for ordinary diagnosis and management of occupational allergic diseases and help the patients.

6.6.2 The Structure of the Guideline

The guideline has a basic structure in which clinical questions are set with reference to Medical Information Network Distribution Service (MINDS); statements by the committee are listed; recommendation grades and evidence levels are defined; descriptions and references are indicated. Also, legal aspects are written in full.

As for occupational allergic diseases, because new substances have been continually produced due to technical innovation and working environments have been changing due to changes in industrial structures, new OAs can always arise. We have revised the guideline in 2016 and will continue to revise it every 3 years, in order to maintein a high level of evidence for the guideline.

6.7 Problems Related to Occupational Asthma in Japan

  1. 1.

    Due to advances in medication, achieving control of symptoms medically tends to be emphasized, and the search for causative allergens tends to be neglected. Thus, physicians often do not try to identify the causative allergen.

  2. 2.

    Poor surveillance data.

  3. 3.

    Poor regulation by law.

  4. 4.

    The work environment has improved in large enterprises under the direction of the government, but the smaller companies are not considered to have made enough effort in some cases.

6.8 Action Plans

  1. 1.

    Make surveillance system/checkup lung conditions of workers regularly.

  2. 2.

    Revise the guidelines of prevention and control of OA at stated periods.

  3. 3.

    OA information center and homepage are required.

  4. 4.

    Share information on OA in other countries.

  5. 5.

    Education about OA for workers, employers, healthcare providers, and government agencies.